Benzyl (piperidin-2-ylmethyl)carbamate

Catalog No. :
ACCDKR281
CAS No. :
184044-09-5
Molecular Formula :
C14H20N2O2
Molecular Weight :
248.33

IUPAC Name:benzyl (piperidin-2-ylmethyl)carbamate

Benzyl (piperidin-2-ylmethyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$81.00Login to see priceInquiryInquiry
250mg95%$137.00Login to see priceInquiryInquiry
1g95%$369.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl (piperidin-2-ylmethyl)carbamate
IUPAC Namebenzyl (piperidin-2-ylmethyl)carbamate
MDL No.MFCD07374332
Molecular FormulaC14H20N2O2
Molecular Weight248.33
SMILESO=C(OCC1=CC=CC=C1)NCC2NCCCC2
InChI KeyBHVZGRBXEXJUCP-UHFFFAOYSA-N
SynonymBenzyl piperidine-2-ylmethylcarbamate;Piperidine-2-ylmethylcarbamic acid benzyl ester;PIPERIDIN-2-YLMETHYL-CARBAMIC ACID BENZYL ESTER;benzyl piperidin-2-ylmethylcarbamate;benzyl piperidin-2-ylmethylcarbamate hydrochloride;PIPERIDIN-2-YLMETHYL-CARBAMIC ACID BENZYL ESTER-HC,L;benzyl N-(piperidin-2-ylMethyl)carbaMate;2-CBZ-aMinoMethyl piperidine-HCl
CAS No.184044-09-5
PubChem CID45072214

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACCDKR281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCDKR281 route product structure diagram
    ACCDKR281184044-09-5
Inquiry

2. ACCDKR281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCDKR281 route product structure diagram
    ACCDKR281184044-09-5
Inquiry

Comments (0)